Agios Pharmaceuticals Inc (NASDAQ:AGIO)
| 47.47 Delayed Data As of Jan 22 |  -0.28 / -0.59%Today’s Change | 27.77 Today|||52-Week Range 56.75 | +9.55% Year-to-Date |
Latest AGIO News | Press Releases
No recent news for Agios Pharmaceuticals Inc.
Today’s Trading
| Previous close | 47.75 |
| Today’s open | 47.05 |
| Day’s range | 46.39 - 47.93 |
| Volume | 18,133 |
| Average volume (3 months) | 815,289 |
| Market cap | $3.2B |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | -13.81% |
| Earnings growth (this year) | +32.05% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | +24.92% |
| P/E ratio | NM |
| Price/Sales | 24.30 |
| Price/Book | 4.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CORTCorcept Therapeutics... | +0.10 | +0.36% |
| ---- | ||
| APLSApellis Pharmaceutic... | -2.42 | -5.04% |
| ALKSAlkermes Plc | +0.72 | +3.35% |
Data as of 4:02pm ET, 01/22/2021
Financials
| Next reporting date | February 18, 2021 |
| EPS forecast (this quarter) | -$1.31 |
| Annual revenue (last year) | $117.9M |
| Annual profit (last year) | -$411.5M |
| Net profit margin | -348.97% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
